Exelead
Paul Morow is a seasoned scientist with extensive experience in analytical chemistry, currently serving in a dual role as a Scientist and Analytical Chemist at Exelead since March 2015. Previous roles include Associate Consultant Chemist at Eli Lilly and Company, where analytical support for pharmaceutical research was provided, and Analytical Chemist positions at Hospira Inc and Abbott Laboratories, focusing on pharmaceutical product development and advanced drug delivery research. Earlier career experience includes roles at Weston Environmental and Silliker Laboratories, where expertise in instrumental analysis and environmental chemistry was developed. Paul Morow holds a Bachelor of Science degree in Biology with a minor in Chemistry from Purdue University Northwest.
This person is not in any teams
Exelead
Scientists are driven by powerful ideas to develop innovative molecules that can save lives. But to bring their drug to market, they must navigate pharmaceutical manufacturing, clinical trials, logistical complexities and strict regulations. Exelead guides you through each step, so you can get your drug to patients that need it. Exelead specializes in manufacturing lipid nanoparticle, liposome, and pegylated formulations. We work with you to bring your drug from development to commercialization. The life science business of Merck KGaA, Darmstadt, Germany, operates as MilliporeSigma in the US and Canada. Merck KGaA, Darmstadt, Germany is a global science and technology company with around 60,000 employees in more than 66 countries. Intended only for US/CA visitors. Learn more: https://www.sigmaaldrich.com/US/en/collections/press/closing-of-exelead-acquisition